Fritsch, Christine
Novartis Institutes for BioMedical Research
2 papers on CoChat
Most cited papers
- Verified
Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity
Maira, S.-M., Stauffer, F., Brueggen, J., Furet, P., Schnell, C., Fritsch, C., Brachmann, S., Chène, P., De Pover, A., Schoemaker, K., et al. (2008) · Molecular Cancer Therapeutics
PI3K/AKT/mTOR signaling in cancerMetabolism, Diabetes, and Cancer
Cited by 1,134
- Verified
Pharmacological and genomic profiling identifies NF-κB-targeted treatment strategies for mantle cell lymphoma
Rahal, R., Frick, M., Romero, R., Korn, J. M., Kridel, R., Chun Chan, F., Meissner, B., Bhang, H.-E., Ruddy, D., Kauffmann, A., et al. (2014) · Nature Medicine
Lymphoma Diagnosis and TreatmentNF-κB Signaling Pathways
Cited by 334
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free